HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katja Zirlik Selected Research

Capecitabine (Xeloda)

12/2016Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katja Zirlik Research Topics

Disease

11B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2024 - 07/2009
11Neoplasms (Cancer)
01/2018 - 04/2006
4B-Cell Lymphoma (Lymphoma, B Cell)
05/2015 - 04/2006
4Atherosclerosis
09/2011 - 04/2010
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018 - 09/2010
2Leukemia
01/2018 - 08/2014
2Trisomy (Trisomies)
01/2018 - 01/2012
2Adenocarcinoma
12/2016 - 03/2014
2Multiple Myeloma
01/2016 - 08/2007
2Inflammation (Inflammations)
09/2011 - 04/2010
2Lymphoma (Lymphomas)
08/2007 - 11/2006
1Melanoma (Melanoma, Malignant)
11/2014
1Multiple Sclerosis
08/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2014
1Esophageal Neoplasms (Esophageal Cancer)
07/2013
1Rheumatoid Arthritis
09/2011
1Asthma (Bronchial Asthma)
09/2011
1Coronary Disease (Coronary Heart Disease)
07/2010
1Atherosclerotic Plaque (Atheroma)
07/2010
1Acute Coronary Syndrome
05/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
05/2010
1Cardiovascular Diseases (Cardiovascular Disease)
04/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2010
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2008
1Plasmacytoma
08/2007
1Hepatitis B
04/2006

Drug/Important Bio-Agent (IBA)

6Syk KinaseIBA
01/2016 - 07/2009
3Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2012
3Phosphotransferases (Kinase)IBA
01/2018 - 02/2014
2B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
05/2015 - 09/2012
2AntigensIBA
09/2012 - 11/2006
2EpitopesIBA
09/2012 - 09/2010
2LigandsIBA
01/2012 - 08/2007
2LDL Receptors (LDL Receptor)IBA
09/2011 - 07/2010
2Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA
09/2010 - 11/2006
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
07/2010 - 05/2010
2Immunoglobulins (Immunoglobulin)IBA
11/2006 - 04/2006
2VaccinesIBA
11/2006 - 04/2006
1idelalisibIBA
01/2018
1Oxygen (Dioxygen)IBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1ibrutinibIBA
01/2018
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1Bendamustine HydrochlorideFDA Link
01/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2018
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2018
1Epirubicin (Ellence)FDA LinkGeneric
12/2016
1Leucovorin (Folinic Acid)FDA Link
12/2016
1Cisplatin (Platino)FDA LinkGeneric
12/2016
1Capecitabine (Xeloda)FDA Link
12/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2016
1Docetaxel (Taxotere)FDA Link
12/2016
1Fluorouracil (Carac)FDA LinkGeneric
12/2016
1Polysaccharides (Glycans)IBA
05/2015
1LectinsIBA
05/2015
1AutoantigensIBA
05/2015
1VemurafenibIBA
11/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2014
1tyrosine receptor (receptor, tyrosine)IBA
11/2014
1A-factor (Streptomyces)IBA
08/2014
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
08/2014
1Sphingosine-1-Phosphate ReceptorsIBA
08/2014
1GTP-Binding Proteins (G-Protein)IBA
08/2014
1proto-oncogene proteins pimIBA
05/2014
1CXCR4 Receptors (CXCR4 Receptor)IBA
05/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2013
1Insulin (Novolin)FDA Link
08/2013
1Complementarity Determining Regions (Complementarity Determining Region)IBA
09/2012
1fostamatinibIBA
09/2011
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
11/2010
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
07/2010
1RNA (Ribonucleic Acid)IBA
07/2010
1CholesterolIBA
07/2010
1Cytotoxins (Cytolysins)IBA
06/2010
1IntegrinsIBA
06/2010
1ChemokinesIBA
06/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010
1Messenger RNA (mRNA)IBA
05/2010
1TNF Receptor-Associated Factor 1IBA
05/2010
1VorinostatFDA Link
05/2010
1CD40 Ligand (CD40L)IBA
04/2010
1Interleukin-6 (Interleukin 6)IBA
04/2010
1CytokinesIBA
04/2010
1Imatinib Mesylate (Gleevec)FDA Link
09/2008
1LipidsIBA
04/2006
1Immunoglobulin Fab FragmentsIBA
04/2006
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2006
1Anti-Idiotypic AntibodiesIBA
04/2006
1Neoplasm Antigens (Tumor Antigens)IBA
04/2006

Therapy/Procedure

4Therapeutics
01/2018 - 08/2007
3Drug Therapy (Chemotherapy)
01/2018 - 03/2014
2Esophagectomy
03/2014 - 07/2013
2Neoadjuvant Therapy
03/2014 - 07/2013
1Intravenous Infusions
12/2016
1Combined Modality Therapy
03/2014
1Transplantation
05/2010